Lab Evolved Enzymes Market Share

  • Report ID: 3914
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Lab Evolved Enzymes Industry - Regional Synopsis

Regionally, the global lab evolved enzymes market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. North America industry is likely to hold largest revenue share by 2037, due to development of novel and superior performing products in the region. In addition, growing usage of enzymes in the pharmaceuticals industry is also expected to accelerate the market growth in the region in the coming years. Moreover, the market in Europe is also projected to grab a notable share during the forecast period, which can be credited to the increasing growth of beef and poultry, which in turn is anticipated to raise the usage of enzymes in feed in the region. As per the statistics provided by the European Union, there were about 146 million pigs, 76 million bovine animals and 75 million sheep and goats in the EU in 2020. The region produced 13.6 million tons of poultry meat that year.

Lab-Evolved-Enzymes-Market-Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Lab Evolved Enzymes Market size is projected to grow at substantial growth rate during the forecast period i.e., between 2025-2037.

The market growth is driven by growing emphasis towards renewable energy, and increasing demand for natural substitute for synthetic chemicals.

North America industry is likely to hold largest revenue share by 2037, due to development of novel and superior performing products in the region.

The major players in the market are AB Enzymes GmbH, 121 Bio, LLC, Aeglea BioTherapeutics, Inc., AM-Pharma B.V., Alphazyme LLC, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos